Evercore ISI Starts MiNK Therapeutics (INKT) at Outperform
Tweet
Share
E-mailGet Alerts INKT Hot Sheet
Price: $0.89 --0%
Rating Summary:
4 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 4 | New: 2
Rating Summary:
4 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 4 | New: 2
Join SI Premium – FREE
Evercore ISI analyst Maneka Mirchandaney initiates coverage on MiNK Therapeutics (NASDAQ: INKT) with a Outperform rating and a price target of $30.00.
For an analyst ratings summary and ratings history on MiNK Therapeutics click here. For more ratings news on MiNK Therapeutics click here.
Shares of MiNK Therapeutics closed at $18.96 yesterday.
You May Also Be Interested In
- Loop Capital Starts MongoDB (MDB) at Buy, '2H Ramp Ahead'
- Canaccord Genuity Starts Pan African Resources PLC (PAF:LN) at Buy
- BofA Securities Reinstates Mahanagar Gas Limited (MAHGL:IN) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
